Tuas (ASX:TUA) M1 deal stalls as IMDA flags an unauthorised spectrum problem at Simba

A 21 May long-stop date and a live regulator investigation now sit on top of the same transaction

The M1 acquisition was meant to be the moment Tuas Limited (ASX:TUA) graduated from scrappy Singaporean challenger to the country’s number three telco at proper scale. On Sunday, that story hit a wall. The Infocomm Media Development Authority of Singapore has suspended its review of the deal first announced in August 2025.

The reason is uncomfortable. The IMDA says it has learned that Simba, Tuas’s operating brand in Singapore, may have been using radio frequency bands it was not authorised to use. If proven, that would breach both the Telecommunications Act and the conditions of Simba’s Facilities-Based Operations Licence.

Simba is co-operating with the regulator. The Tuas board is now also running its own review of the alleged unauthorised spectrum use. Sitting on top of all this is a Share Purchase Agreement with a long-stop date of 21 May 2026, just three days away from today’s announcement, which leaves Tuas almost no runway to resolve the regulatory cloud before contractual deadlines bite.

Why the spectrum allegation matters more than a typical regulatory delay

Telco regulators are not in the habit of suspending merger reviews. They usually negotiate undertakings, extend timelines or impose conditions. A full suspension because the acquirer itself may have broken its operating licence is a different category of problem.

Spectrum is the core asset Tuas runs its network on. If Simba has been transmitting on bands it was not authorised to use, the consequences range from fines and remediation costs through to licence conditions being tightened. In the worst scenario, the IMDA could decide Tuas is not a fit acquirer for an incumbent licensee like M1.

We think the market will price this as a binary risk rather than a probability. Either the issue is narrow and technical and the M1 deal eventually proceeds, or it is structural and the entire growth thesis needs rebasing.

The 21 May long-stop date is the next pressure point

The Share Purchase Agreement long-stop date falls on 21 May 2026. That is the contractual deadline by which conditions, including regulatory approvals, need to be satisfied or the counterparties can walk.

Tuas has confirmed discussions with the counterparties are ongoing. The realistic outcomes are an extension of the long-stop, a renegotiation of price or conditions to reflect the new risk, or termination. None of those are neutral for the share price.

M1’s vendors also have leverage here that they did not have a week ago. Any extension is likely to come with something attached, whether that is a price adjustment, a break fee structure or tighter conditions precedent.

What this does to the Tuas equity story

Tuas listed in 2020 as a TPG Telecom spin-off and has spent the years since steadily taking mobile share in Singapore on the back of David Teoh’s low-cost playbook. The investment case has always rested on two pillars. Subscriber growth in the existing Simba business, and the optionality of moving up the stack through M1.

Pillar one is unchanged this morning. Pillar two has just become considerably more fragile. Even if the M1 deal eventually closes, the path to it now runs through a regulator that is actively investigating the acquirer.

The more immediate question is what the spectrum review uncovers about Simba’s standalone business. A finding that requires remediation, fines or operational changes would hit the part of Tuas that was supposed to be the safe half of the story.

The Investors Takeaway for Tuas Limited

By 21 May the market should know whether the long-stop is extended, renegotiated or allowed to lapse. That single outcome will shape how investors think about Tuas for the rest of the calendar year. An extension keeps the M1 thesis alive, even if bruised. A lapse forces the market to value Tuas purely on Simba, with a regulator looking over the shoulder.

Our concern is that even the more benign outcomes here carry a tail. A spectrum compliance finding does not disappear when a deal closes. It follows the licensee. Investors looking for context on how regulatory and policy shifts can reshape an investment case can read our earlier work at stocksdownunder, which sits in a different sector but rhymes on the same theme.

We would want to see two things before getting constructive again. A clear statement of scope from the IMDA on what bands and what period are under review. And a counterparty position from M1’s vendors that signals the deal is being reshaped rather than walked away from.